Gene: LDLRAD2
Official Full Name: low density lipoprotein receptor class A domain containing 2provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21335 | LDLRAD2 Knockout cell line (HeLa) | Human | LDLRAD2 | 1:3~1:6 | Negative | Online Inquiry |
LDLRAD2 Gene Knockout Cell Lines represent a vital tool in molecular biology, specifically designed to facilitate in-depth studies of the LDLRAD2 gene's function and its role in lipid metabolism and cardiovascular diseases. These genetically modified cell lines are characterized by the precise knockout of the LDLRAD2 gene, achieved through advanced CRISPR-Cas9 genome editing techniques. As a result, researchers can examine the physiological and biochemical changes that occur in the absence of this gene, allowing for a clearer understanding of its mechanisms and the underlying pathways it influences.
The primary function of LDLRAD2 involves the regulation of lipoprotein metabolism and receptor-mediated endocytosis, processes intricately tied to the development of atherosclerosis and other metabolic disorders. By using LDLRAD2 knockout cell lines, scientists can manipulate cellular environments to study how the absence of this gene affects lipid uptake, cellular signaling, and overall cellular health. This makes them invaluable for research aimed at elucidating the complexities of human diseases associated with lipid dysregulation.
In clinical and research settings, these cell lines hold significant promise for drug development and therapeutic interventions. They offer a unique platform for screening potential pharmacological agents that target lipid metabolism, thus providing insights that could lead to novel treatment strategies for cardiovascular diseases. Compared to traditional wild-type cell lines, LDLRAD2 knockout models exhibit heightened sensitivity to changes in lipid levels, making them a superior choice for experimental studies aimed at elucidating the role of LDLRAD2 in health and disease.
One of the key advantages of using our LDLRAD2 Gene Knockout Cell Lines lies in their reproducibility and reliability, derived from our rigorous quality assurance protocols. Researchers benefit from consistent performance across experiments, which enhances the reliability of data collected. Moreover, the ease of use and availability of detailed protocols allow for rapid adaptation in various laboratory settings.
Overall, LSDRAD2 Gene Knockout Cell Lines are more than just a research tool; they are a gateway to new discoveries in the field of cardiac health and metabolic regulation. At [Company Name], we pride ourselves on our expertise in developing innovative biological products tailored for cutting-edge research, ensuring that our clients are equipped with the best resources to advance their scientific inquiries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.